We are a platform created in collaboration with "Young Scientists" and stakeholders who believe in the future of Turkey, under the leadership of BioExpo, which hosts science-based fairs and events with the cooperation of Academia, Industry, and Public Institutions in the field of Life Sciences. As Bio-X, we always keep our doors open to scientific discoveries, innovations, and collaborations. As an academia-industry network, we aim to bridge different sectors, increase the potential in life sciences, and contribute to Turkey's progress in science and technology.

BM Labosis, established in 2006 in Ankara, is an R&D and representation company operating in the fields of Life Sciences, Molecular Biology, and Biotechnology. We provide measurement devices, reagents, enzymes, and research services required by production and analysis laboratories in the pharmaceutical, food, and environmental industries. We deliver both locally produced and imported products to production and R&D laboratories in the private sector, public institutions, and universities with the highest quality of service and technical support. In our molecular biology laboratory, we test imported products and offer solutions in product development and research projects with our expert team.

Boğaziçi University Center for Targeted Therapy Technologies (CT3), founded on the basis of the Boğaziçi University Life Sciences and Technologies Application and Research Center (LifeSci) which established in 2010, integrates experts from 13 departments to conduct interdisciplinary research in life sciences, health, and biotechnology. With advanced infrastructure, the center pioneers innovative technologies, including cancer diagnostics, drug delivery systems, and biosensing platforms. CT3 is the new center established with Ministry support for LifeSci, which has completed over 100 projects, published 1,200 high-impact papers, and holds 13 international patents. Supported by national and EU funds, CT3 aims to accelerate innovations that benefit both the Turkish economy and global health through collaboration between academia and industry.

Çanakkale Onsekiz Mart University (ÇOMÜ), established in 1992 in Çanakkale, a city renowned for its historical and cultural heritage, is one of Turkey's leading higher education institutions. With over 45,000 students, a robust research infrastructure, and a dedicated academic staff, ÇOMÜ continues to pursue excellence in education, scientific research, and community service. The university stands as a key educational hub in the region through its national and international academic collaborations. ÇOMÜ offers a wide range of undergraduate, graduate, and doctoral programs with a focus on innovative and high-quality education. Our research-driven laboratories and practical training opportunities equip students to compete on a global scale. Moreover, the university plays a pioneering role in entrepreneurship and innovation, hosting a technology development zone and leading numerous R&D projects. ÇOMÜ’s strong academic foundation, combined with the strategic location and natural beauty of Çanakkale, has positioned the university as a globally recognized center for education and research. We remain committed to transforming scientific advancements into societal benefits and continue to educate the leaders of tomorrow.

Data Management 365 is a software company with deep expertise in clinical trials. We emphasize robust skills in Clinical Data Management and Data Science, enabling us to address Data Managers’ challenges, enhance our MainEDC™ platform through real-time feedback, and share best practices with clients.  We have developed and continue to develop a platform for any medical research and provide technology transfer for advanced data collection, processing and presentation. We have integrated EDC, IRT, eCOA, eConsent, RBM, PACS and Artificial Intelligence into a single software
solution – the MainEDC™ ecosystem.

EMA Engineering provides services in the field of process equipment for the Turkish pharmaceutical and biotechnology sector. The innovative engineering solutions it offers are based on 30 years of industry experience. It carries out the sales, after-sales support and design of the products it represents in Turkey. It can also provide process engineering and cGMP consultancy services within the scope of the project.

Institute of Biotechnology, which was established at the same time as the conversion of the Gebze Institute of Technology to Gebze Technical University, aims to coordinate Master of Science programs with and without thesis as well as PhD programs together with industry, with the vision of equipping its graduates with bioentrepreneurial skills. Along with the fact that Gebze Technical University resides within several Industrial Zones of Tuzla, Gebze and Kocaeli, its partnership with Kocaeli Silicon Valley project drives our university – in collaboration with Technology Transfer Office - towards supporting industrial R&D activities through research that solves sectoral problems in addition to education skilled R&D personnel.

HRZ Biotechnology ensures 100% domestic production of recombinant proteins using advanced technology, meeting market demands. Established in March 2009 at Istanbul Technical University's Department of Molecular Biology and Genetics, our laboratory has continuously utilized its R&D infrastructure to develop and manufacture Turkey's essential biotechnological products such as enzymes and antibodies.In addition to biotechnological products, we design and domestically produce real-time PCR kits for disease diagnostics. With a strong background in research and ongoing development, our company aims to meet market needs by developing and manufacturing various proteins and kits.Benefiting from our extensive research capabilities, we have successfully completed numerous projects supported by TÜBİTAK, KAMAG, ISTKA, and KOSGEB, with many ongoing. Leveraging our experience in this field, we strive to contribute high value-added products to our country tailored to our customers' needs. Powered by domestic production, we efficiently supply biotechnological products across all sectors at competitive prices.

T.R. No. 29290, dated 9 March 2015, accepted by the Turkish Grand National Assembly on 16/02/2015. With the decision number 2015/7321 published in the Official Gazette, it was decided to change the name of the Hemodialysis-Transplantation Institute within the Rectorate of Dokuz Eylül University to Izmir International Biomedicine and Genome Institute, and our institute started its educational activities. The first student recruitment to our institute was made in the 2016-2017 academic year. The Department of Genomic Sciences and Biotechnology was established within our institute and started its educational activities. Master's and PhD students study in this department. There are 1 associate professor and 3 doctor faculty members in the institute staff within the department. These faculty members carry out our academic activities by assigning them from other academic units of our university. Our Biomedicine and Health Technologies department, which was opened at the establishment of our institute, has not started its educational activities yet. He started teaching with the Molecular Biology and Genetics Master's and Doctoral Programs affiliated with the Department of Genome Sciences and Molecular Biotechnology at the Izmir International Biomedicine and Genome Institute, which was established on 16/02/2015. With the senate decision numbered 439 meeting dated 07/04/2015 and the YÖK Board decision dated 28/04/2015, the "Department of Genomic Sciences and Molecular Biotechnology" and the "Department of Biomedicine and Health Technologies" were established. In its initial establishment phase, our institute operated within the Izmir Biomedicine and Genome Center until February 2018, and after this date, the center and the institute continue their activities separately. Our university rector, Prof., during the establishment phase of our institute. Dr. Mehmet Füzün, our founding director Prof.Dr. It was opened with the participation of Mehmet Öztürk, Minister of Science, Industry and Technology Fikri Işık, Izmir Governor Mustafa Toprak, Nobel Prize winner Sir Tim Hunt, as well as many local and foreign scientists. Our institute started its activities in the same building with the Izmir Biomedicine and Genome Center during its initial establishment phase and currently continues its activities in the same building.

LabMedya, as can be understood from its name, is a publication which has been serving as a media channel in laboratory sector for approximately 15 years and which is followed with a huge interest and curiosity. It has become a publication each issue of which is looked forward to as its contents cover completely independent, free and sectoral issues. It publishes between 7.000 and 10.000 issues every two months. Our publication is mailed to the name of the person directly by mail as a free of charge. In addition, our publication can be read online and interactively through our web page and mobile application. Also soft copies are sent via e-mail to approximately 30.000 people in the sector which are in our e-mail bank. LabMedya, which is also popular in social media, is followed more and more every day. Our vision is to become a publication which will attract the attention of people, which will be read and each issue of which will be looked forward to in all terms.

NAYA Cleanrooms is a specialist in Cleanrooms, with 30+ years experience in Design, Construction, Installation and Validation. With over 200 skilled employees, production facilities and offices in Turkey, North Macedonia and Slovenia; they are a leading International Turn-Key Cleanroom Contractor and the only potential partner you would need for every aspect of your Cleanroom project.

Sabancı University Nanotechnology Research and Application Center (SUNUM) was established in 2010 and that started its activities as a "National Research Infrastructure under the law numbered 6550 since 2017. SUNUM’s research areas with its competent infrastructure in areas such as the design, synthesis, and characterization of nanomaterials and nanostructures, as well as the design and production of micro-nano systems developed from nanostructures. These activities span various application areas, including medicine, chemistry, pharmaceuticals, energy, cosmetics, automotive, agriculture, food, and environmental sectors. SUNUM, which has a research staff of over 200 researchers, is working to become a continuously developing, sustainable, globally exemplary and leading Center of Excellence, open to all stakeholders, in cooperation with approximately 500 institutions, more than 100 of which are international.